MEDICAL TREATMENT MONITORING SYSTEM AND METHOD

• US 20110112860A1
• Filed: 01/18/2011
• Published: 05/12/2011
• Est. Priority Date: 07/28/2004
• Status: Abandoned Application

• Current Assignee: Madrigal Health, LLC
• Original Assignee: Informedix, Inc. (Informedix Holdings, Inc.)
• Inventors: KEHR, Bruce A.
• Application Number:
  US13/008,476
• Publication Number:
  US 20110112860A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/60 for the operation of medical equipment or devices
• CPC Class Codes: G16H 50/70 for mining of medical data, e.g. analysing previous cases of other patients
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

A method and system is provided for monitoring the treatment of one or more patients with one or more medications. A medical treatment plan is defined as a set of data elements stored in a database and representative of a patient configuration file. The data elements are translated into a sequence of prompt and record events, which are communicated to one or more remote monitoring devices. Patient response data, supplied by the patients in response to the events and relating at least in part to a record of the intake of the medication by the patient, are obtained, recorded, and uploaded into the database. The patient response data are correlated with additional data relating to patient health or economic outcomes, for example using statistical analysis and data mining. The correlation can be used to adjust dosing recommendations to improve clinical outcome, reduce side-effects, and eliminate drug interactions.

Claims

1. A method of monitoring a treatment of a patient with a medication, the method comprising:

implementing a data processing apparatus for defining a medical treatment plan as a template which contains a plurality of data elements and storing the template in a database that is linked through a communications network to at least one remote monitoring device, the medical treatment plan describing a treatment of a group comprised of two or more patients with the medication;

transmitting the medical treatment plan to the monitoring device over the network, and obtaining patient response data supplied by the patient in response to the data elements, the patient response data relating at least in part to a record of the intake of the medication by the patient; and

providing a report of said patient response data for a selected range of dates comprising one or more days.

2. A method in accordance with claim 1, wherein the report relates to data for an individual patient.

3. A method in accordance with claim 1, wherein the report relates to data for a group of patients.

4. A method in accordance with claim 1, wherein the report includes patient response data that is correlated with additional data relating to one or more patient outcomes, to determine the relationship between the medication intake by the patient and the patient outcomes.

5. A method in accordance with claim 1, wherein the step of correlating the patient data with additional data comprises:

combining the patient data with the additional data; and

performing data mining and statistical analysis of the combined data; and

providing a report of said analysis.

6. A method in accordance with claim 1, further comprising the step of using the reported correlation between the patient response data and the additional data to adjust the recommended dosing instructions for the medication.

7. A method in accordance with claim 4, further comprising the step of using the reported correlation between the patient response data and the additional data to adjust the recommended dosing instructions for the medication.

8. A method in accordance with claim 5, further comprising the act of using the reported correlation between the patient response data and the additional data to adjust the recommended dosing instructions for the medication.

9. A method in accordance with claim 1, wherein the patient response data relate to at least one of:

patient compliance to intake of the medication;

patient'"'"'s answers to one or more health status questions;

patient'"'"'s answers to one or more quality of life questionnaires;

patient physiologic data; and

patient laboratory data.

10. A method in accordance with claim 1, wherein the additional data comprise at least one of:

patient genomic data, patient proteomic data, patient phenotypic data, patient economic data, and patient healthcare data; and

wherein the additional data relate to at least one of;

a medication side effect;

the patient'"'"'s health status;

the patient'"'"'s quality of life;

the patient'"'"'s physiologic status;

the patient'"'"'s genotype;

a resulting value of a laboratory test performed on the patient;

a serum protein;

a cell surface receptor;

an economic cost of medication treatment; and

an interaction between two or more drugs.

11. A method in accordance with claim 4, further comprising the step of updating one or more of the patient medical treatment plans, in response to the report.

12. A method in accordance with claim 1, wherein the data elements stored in the database relate to at least one of:

instructions relating to the medication;

medical educational content regarding the medication;

intake dosage for the medication;

physiological measurement of the patient;

one or more cell surface receptors;

one or more serum proteins;

DNA data;

protein data;

psychological measurement of the patient,

instructions or medical education content related to a disease state or a medical condition of the patient;

a pathogen or a class of pathogen;

instructions or medical educational content related to a viral infection, or upon a specific viral disease such as HIV/AIDS, hepatitis A, B, C, D, E or G;

instructions or medical educational relating to one of a bacterial disease agent and a microbial agent; and

instructions or medical educational content relating to a type of disease or to a pathology of a physiological system.

13. A method in accordance with claim 12,

wherein the physiological measurement of the patient comprises at least one of:

weight, blood pressure, pulse rate, glucose level, an antigen level, pH, pO₂, temperature, EKG rhythm, pO2 saturation of the blood, and hormone level; and

wherein the psychological measurement comprises a score based upon one or more standardized or non-standardized tests that measure at least one of;

anxiety, stress, anger, suicidal tendencies, schizophrenic relapse, rapid cycling bipolar relapse, and confusion.

14. A method in accordance with claim 12, wherein the disease state or medical condition of the patient comprises at least one of:

congestive heart failure, hypertension, angina, circulatory inadequacy or other disease condition of the cardiopulmonary and circulatory systems, specific organ failure, dysfunction of an organ or system or transplanted organ, including asthma for the lungs, kidney failure for the kidney, arteriosclerosis or atherosclerosis of the heart, and transplantation of lung, kidney or heart;

wherein the bacterial disease agent comprises a bacterial agent for at least one of;

tuberculosis, malaria, cholera, and meningitis, and

wherein the microbial agent comprises a virus, a bacteria, a microbial agent for mycotic infection, and a microbial agent for parasitic infection;

wherein the type of disease comprises cancer and autoimmune disease; and

wherein the pathology of the physiological system comprises a pathology of the muscular-skeletal, hematopoetic, circulatory, reproductive, dermatologic, digestive, endocrine or nervous systems.

15. A method in accordance with claim 1, wherein the report indicates whether the patient is stable, better or worse.

16. A system for monitoring the effect of a medication on one or more patients, the system comprising:

a database configured to store therein a plurality of data elements representative of a medical treatment plan for treating the patients with the medication, the database being linked through a communications network to at least one remote monitoring device configured for use by the patients; and

a controller for controlling access to the database and for controlling communications over the network;

wherein the controller is configured to transform the data elements into a sequence of prompt and record events, and to cause the sequence of events to be communicated to the remote monitoring device over the network;

wherein the controller is further configured to receive patient response data supplied by the patients in response to the sequence of events, and to upload the patient response data onto the database; and

wherein the controller is further configured to correlate the patient response data with additional data relating to one or more patient outcomes; and

means for providing a report of said correlation for a selected range of dates comprising one or more days.

17. A method system in accordance with claim 16, wherein the report relates to data for an individual patient.

18. A method in accordance with claim 16, wherein the report relates to data for a group of patients.

19. A method in accordance with claim 16, wherein the report includes patient response data that is correlated with additional data relating to one or more patient outcomes, to determine the relationship between the medication intake by the patient and the patient outcomes.

20. A method in accordance with claim 16, wherein the act of correlating the patient data with additional data comprises:

combining the patient data with the additional data and

performing data mining and statistical analysis of the combined data; and

providing a report of said analysis.

21. A system in accordance with claim 16, wherein the controller is further configured to adjust one or more recommended dosing instructions for the medication, using the correlation between the patient response data and the additional data.

22. A system in accordance with claim 16, wherein the patient response data provide information relating to at least one of:

patients'"'"' compliance to intake of the medication;

patients'"'"' answers to one or more health status questions;

patients'"'"' answers to one or more quality of life questionnaires;

patients'"'"'physiologic data; and

patients'"'"' laboratory data.

23. A system in accordance with claim 16, wherein the additional data comprise at least one of:

patient genomic data, patient proteomic data, patient phenotypic data, patient economic data, and patient healthcare data; and

wherein the additional data relate to at least one of;

a medication side effect;

patients'"'"' health status;

patients'"'"' quality of life;

patients'"'"' physiologic status;

patients'"'"' genotype;

a resulting value of a laboratory test performed on one or more patients;

a serum protein;

a cell surface receptor;

an economic cost of medication treatment; and

an interaction between two or more drugs.

24. A system in accordance with claim 16, wherein the data elements stored in the database relate to at least one of:

instructions relating to the medication;

medical educational content regarding the medication;

intake dosage for the medication;

physiological measurement of one or more patients;

one or more cell surface receptors;

one or more serum proteins;

DNA data;

protein data;

psychological measurement of one or more patients,

instructions or medical education content related to a disease state or a medical condition of one or more patients;

a pathogen or a class of pathogen;

instructions or medical educational content related to a viral infection, or upon a specific viral disease such as HIV/AIDS, hepatitis A, B, C, D, E or G;

instructions or medical educational relating to one of a bacterial disease agent and a microbial agent; and

instructions or medical educational content relating to a type of disease or to a pathology of a physiological system.

25. A system in accordance with claim 16, further comprising a user interface configured to provide user access to the database for one or more users.

26. A system in accordance with claim 16, further comprising a security module configured to perform a security check on at least one of:

data that is input into the database;

data that is output from the database; and

users that seek to access the database.

31. A system in accordance with claim 16, wherein the controller is further configured to adjust the recommended dosing instructions for the medication, based on the correlation between the patient response data and the additional data.

33. A system in accordance with claim 16, wherein the controller is further configured to adjust the recommended dosing instructions for the medication for a specific population of patients, based upon one or more characteristics shared by said population of patients, and based on the correlation between the patient response data and the additional data, so as to reduce the likelihood of medication side effects in said population, and so as to reduce the likelihood of drug interactions between two or more drugs.

27. A machine-readable medium having stored therein instructions that, when executed by a computer, cause the computer to:

create a medical treatment plan for treating a patient with a medication and store the medical treatment plan as a plurality of data elements in a database that is linked through a communications network to at least one remote monitoring device configured for use by the patient;

transform the data elements into a sequence of prompt and record events;

communicate the sequence of events to the patient over the network, and obtain patient response data supplied by the patient in response to the sequence of events, the patient response data relating at least in part to a record of an intake of the medication by the patient;

upload the patient response data onto the database; and

correlate the patient response data with additional data relating to one or more patient outcomes, to determine the relationship between the intake of the medication and the patient outcomes; and

provide a report of said patient response data for a selected range of dates comprising one or more days.

28. A computer system for monitoring the effect of a medication on a patient, the system comprising:

means for creating a medical treatment plan for treating the patient with the medication, wherein the medical treatment plan is defined as a plurality of data elements representing one or more configuration files for the patient;

means for storing the plurality of data elements;

means for translating the data elements into a sequence of prompt and record events;

means for communicating the sequence of events over a network to a remote monitoring device usable by the patient;

means for obtaining patient response data supplied by the patient in response to the data elements, and for uploading the patient response data onto the database, the patient response data relating at least in part to a record to the intake of the medication by the patient; and

means for correlating the patient response data with additional data relating to one or more patient outcomes; and

means for providing a report of said patient response data for a selected range of dates comprising one or more days.

29. (canceled)

30. (canceled)

32. (canceled)